Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer

Cancer Research

Volumn 72, Issue 8, 2012, Pages 1921-1928

  Asmann, Yan W ^a   Necela, Brian M ^b   Kalari, Krishna R ^b   Hossain, Asif ^a   Baker, Tiffany R ^b   Carr, Jennifer M ^b   Davis, Caroline ^b   Getz, Julie E ^c   Hostetter, Galen ^c   Li, Xing ^a   McLaughlin, Sarah A ^b   Radisky, Derek C ^b   Schroth, Gary P ^d   Cunliffe, Heather E ^c   Perez, Edith A ^b   Thompson, E Aubrey ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d ILLUMINA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; FUSION GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE PRODUCT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIMARY TUMOR; PRIORITY JOURNAL; TISSUE SECTION; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; FEMALE; GENETIC TECHNIQUES; HUMANS; ONCOGENE PROTEINS, FUSION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RNA, MESSENGER; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 84860117771     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3142     Document Type: Article

References (21)

1. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-mall-cell lung cancer. Nature 2007;448:561-6. (Pubitemid 47206930)
2. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer 2008;8:497-511.
3. Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci U S A 2009;106:12353-8.
4. Inaki K, Hillmer AM, Ukil L, Yao F, Woo XY, Vardy LA, et al. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Res 2011;21:676-87.
5. Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, et al. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 2011;12:R6.
6. Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, Sun Z, et al. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 2011;39:e100.
7. Guffanti A, Iacono M, Pelucchi P, Kim N, Solda G, Croft LJ, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 2009;10:163.
8. Hillmer AM, Yao F, Inaki K, Lee WH, Ariyaratne PN, Teo AS, et al. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. Genome Res 2011;21:665-75.
9. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009;462:1005-10.
10. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk, Mathers JA, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002;2:367-76. (Pubitemid 41039103)
11. Sun Z, Asmann YW, Kalari KR, Bot B, Eckel-Passow JE, Baker TR, et al. Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. PLoS ONE 2011;6:e17490.
12. ArrayExpress. Body Map 2.0, query ID: E-MTAB-513. [cited]. Available from: http://www.ebi.ac.uk/arrayexpress.
13. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-60.
14. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009;25:2078-9.
15. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009;458:97-101.
16. Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F, et al. Integrated profiling of basal and luminal breast cancers. Cancer Res 2007;67:11565-75.
17. Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, et al. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 2009;15:441-51.
18. Bae JS, Choi JS, Baik SH, Park WC, Song BJ, Kim JS, et al. Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. World J Surg Oncol 2010;8:32.
19. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010;42:885-92.
20. Yang TL, Su YR, Huang CS, Yu JC, Lo YL, Wu PE, et al. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity. Genes Chromosomes Cancer 2004;41:250-6.
21. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007;315:1576-9. (Pubitemid 46449474)